Alvaro Simba-Lahuasi

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Antiretroviral Therapy

Respiratory Syndrome Coronavirus

Human Immunodeficiency Virus

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M Luis Rodríguez, Vicente Marchán, Kris M White, Adolfo García-Sastre, José Gallego
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Alvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M Luis Rodríguez, Vicente Marchán, Kris M White, Adolfo García-Sastre, José Gallego
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Alvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M Luis Rodríguez, Vicente Marchán, Kris M White, Adolfo García-Sastre, José Gallego
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Alvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M Luis Rodríguez, Vicente Marchán, Kris M White, Adolfo García-Sastre, José Gallego
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)